Mesenchymal Stem Cell Therapy for Osteoarthritis from Canada
Allogeneic mesenchymal stem cells (MSCs) derived from umbilical cord tissue, expanded and cryopreserved for intra-articular injection to reduce inflammation in knee osteoarthritis. Falls under HTS 3002.51.00.00 as cell therapy products due to their modified cell culture status for regenerative therapeutic purposes. These biologics promote cartilage repair via immunomodulatory effects.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Verify GMP-compliant manufacturing and donor screening certificates to meet FDA regenerative medicine standards
• Use dry shippers or liquid nitrogen dewars for transport; monitor temperature excursions with data loggers